{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:02:13Z","timestamp":1783422133624,"version":"3.54.6"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Bronchiectasis is characterized by systemic inflammation and multiple comorbidities. This study aimed to investigate the clinical outcomes based on the bronchiectasis etiology comorbidity index (BACI) score in patients hospitalized for severe bronchiectasis exacerbations. We included non-cystic fibrosis patients hospitalized for severe bronchiectasis exacerbations between January 2008 and December 2016 from the Chang Gung Research Database (CGRD) cohort. The main outcome was the 1-year mortality rate after severe exacerbations. We used the Cox regression model to assess the risk factors of 1-year mortality. Of 1,235 patients who were hospitalized for severe bronchiectasis exacerbations, 641 were in the BACI &amp;lt; 6 group and 594 in the BACI \u2265 6 group. The BACI \u2265 6 group had more previous exacerbations and a lower FEV<jats:sub>1<\/jats:sub>. <jats:italic>Pseudomonas aeruginosa<\/jats:italic> (19.1%) was the most common bacterium, followed by <jats:italic>Klebsiella pneumoniae<\/jats:italic> (7.5%). Overall, 11.8% of patients had respiratory failure and the hospital mortality was 3.0%. After discharge, compared to the BACI &amp;lt; 6 group, the BACI \u2265 6 group had a significantly higher cumulative incidence of respiratory failure and mortality in a 1-year follow-up. The risk factors for 1-year mortality in a multivariate analysis include age [hazard ratio (HR) 4.38, <jats:italic>p<\/jats:italic> = 0.01], being male (HR 4.38, <jats:italic>p<\/jats:italic> = 0.01), and systemic corticosteroid usage (HR 6.35, <jats:italic>p<\/jats:italic> = 0.001), while airway clearance therapy (ACT) (HR 0.50, <jats:italic>p<\/jats:italic> = 0.010) was associated with a lower mortality risk. An increased risk of respiratory failure and mortality in a 1-year follow-up after severe exacerbations was observed in bronchiectasis patients with multimorbidities, particularly older age patients, male patients, and patients with a history of systemic corticosteroid use. ACT could effectively improve the risk for 1-year mortality.<\/jats:p>","DOI":"10.3389\/fmed.2021.812775","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T08:53:00Z","timestamp":1642755180000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Influence of Comorbidities and Airway Clearance on Mortality and Outcomes of Patients With Severe Bronchiectasis Exacerbations in Taiwan"],"prefix":"10.3389","volume":"8","author":[{"given":"Hung-Yu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Tsai","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Te","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ting","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chuan","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng-Chyuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian Fan","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","article-title":"Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study","volume":"4","author":"McDonnell","year":"2016","journal-title":"Lancet Respir Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am J Respir Crit Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12931-017-0659-x","article-title":"Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study","volume":"18","author":"Menendez","year":"2017","journal-title":"Respir Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Am J Respir Crit Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score","volume":"43","author":"Martinez-Garcia","year":"2014","journal-title":"Eur Respir J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.21037\/jtd.2017.08.53","article-title":"Distance-saturation product of the 6-minute walk test predicts mortality of patients with non-cystic fibrosis bronchiectasis","volume":"9","author":"Hsieh","year":"2017","journal-title":"J Thorac Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12931-019-1243-3","article-title":"Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis","volume":"20","author":"Sin","year":"2019","journal-title":"Respir Res."},{"key":"B8","first-page":"6","article-title":"Inflammation: a two-edged sword\u2013the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis Suppl."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3390\/jcm9082339","article-title":"Hospitalizations for community-acquired and non-ventilator-associated hospital-acquired pneumonia in Spain: influence of the presence of aronchiectasis. A retrospective database study","volume":"9","author":"Sanchez-Munoz","year":"2020","journal-title":"J Clin Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.rmed.2013.12.015","article-title":"Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis","volume":"108","author":"Goeminne","year":"2014","journal-title":"Respir Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1183\/09031936.97.10122784","article-title":"Bronchiectasis: an orphan disease with a poorly-understood prognosis","volume":"10","author":"Keistinen","year":"1997","journal-title":"Eur Respir J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1038\/s41598-021-86407-8","article-title":"Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities","volume":"11","author":"Choi","year":"2021","journal-title":"Sci Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12890-020-1080-7","article-title":"Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Pulm Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/thoraxjnl-2011-200206","article-title":"Immunity and bacterial colonisation in bronchiectasis","volume":"67","author":"Whitters","year":"2012","journal-title":"Thorax."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European respiratory society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1183\/09031936.00055509","article-title":"A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis","volume":"34","author":"Murray","year":"2009","journal-title":"Eur Respir J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"CD008351","DOI":"10.1002\/14651858.CD008351.pub3","article-title":"Airway clearance techniques for bronchiectasis","volume":"11","author":"Lee","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/resp.13459","article-title":"Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis","volume":"24","author":"O'Neill","year":"2019","journal-title":"Respirology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1269","DOI":"10.1016\/S2214-109X(19)30327-4","article-title":"Bronchiectasis in India: results from the European multicentre bronchiectasis audit and research collaboration (EMBARC) and respiratory research network of India registry","volume":"7","author":"Dhar","year":"2019","journal-title":"Lancet Glob Health."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.chest.2020.06.050","article-title":"Airway clearance techniques in bronchiectasis: analysis from the united states bronchiectasis and non-TB mycobacteria research registry","volume":"158","author":"Basavaraj","year":"2020","journal-title":"Chest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.chest.2020.07.062","article-title":"Using airway clearance techniques in bronchiectasis: halfway there","volume":"158","author":"Spinou","year":"2020","journal-title":"Chest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1901610","DOI":"10.1183\/13993003.01610-2019","article-title":"Respiratory physiotherapy in the bronchiectasis guidelines: is there a loud voice we are yet to hear?","volume":"54","author":"Spinou","year":"2019","journal-title":"Eur Respir J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/pds.4713","article-title":"The chang gung research database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan","volume":"28","author":"Shao","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bj.2017.08.002","article-title":"Chang gung research database: a multi-institutional database consisting of original medical records","volume":"40","author":"Tsai","year":"2017","journal-title":"Biomed J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British thoracic society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1700051","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur Respir J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.4244\/EIJ-D-16-00840","article-title":"Effect of early percutaneous coronary intervention on one-year risk of pneumonia and pneumonia-related adverse outcomes in patients with acute myocardial infarction","volume":"13","author":"Lin","year":"2018","journal-title":"EuroIntervention"},{"key":"B28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3389\/fphar.2019.00908","article-title":"The association between usage of colchicine and pneumonia: a nationwide population-based cohort study","volume":"10","author":"Tsai","year":"2019","journal-title":"Front Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/ijerph17010356","article-title":"The association of periodontal treatment and decreased pneumonia: a nationwide population-based cohort study","volume":"17","author":"Yang","year":"2020","journal-title":"Int J Environ Res Public Health."},{"key":"B30","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00134-009-1743-6","article-title":"Noninvasive and invasive ventilation in acute respiratory failure associated with bronchiectasis","volume":"36","author":"Phua","year":"2010","journal-title":"Intensive Care Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/COPD.S121943","article-title":"Predicting high risk of exacerbations in bronchiectasis: the E-FACED score","volume":"12","author":"Martinez-Garcia","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12890-019-0794-x","article-title":"Oxygen desaturation during the 6-min walk test as a risk for osteoporosis in non-cystic fibrosis bronchiectasis","volume":"19","author":"Huang","year":"2019","journal-title":"BMC Pulm Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cmi.2019.07.010","article-title":"How does pseudomonas aeruginosa affect the progression of bronchiectasis?","volume":"26","author":"Chai","year":"2020","journal-title":"Clin Microbiol Infect."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1513\/AnnalsATS.201506-333OC","article-title":"A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Ann Am Thorac Soc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s12879-017-2754-5","article-title":"Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations","volume":"17","author":"Menendez","year":"2017","journal-title":"BMC Infect Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e552","DOI":"10.1093\/cid\/ciaa1267","article-title":"Reduction in expected survival associated with nontuberculous mycobacterial pulmonary disease","volume":"72","author":"Mourad","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","article-title":"Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis","volume":"7","author":"Chalmers","year":"2019","journal-title":"Lancet Respir Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"209","author":"Altenburg","year":"2013","journal-title":"JAMA."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British thoracic society guideline for bronchiectasis in adults","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1701926","DOI":"10.1183\/13993003.01926-2017","article-title":"Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial","volume":"51","author":"Munoz","year":"2018","journal-title":"Eur Respir J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/00003246-197809000-00004","article-title":"The effects of expiratory positive airway pressure on functional residual capacity in normal subjects","volume":"6","author":"Garrard","year":"1978","journal-title":"Crit Care Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/00325481.1976.11714357","article-title":"Intermittent positive-pressure breathing. A critical appraisal","volume":"59","author":"Fouts","year":"1976","journal-title":"Postgrad Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1056\/NEJM197809212991203","article-title":"Efficacy of chest physiotherapy and intermittent positive-pressure breathing in the resolution of pneumonia","volume":"299","author":"Graham","year":"1978","journal-title":"N Engl J Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1164\/ajrccm.155.6.9196111","article-title":"Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis","volume":"155","author":"Lin","year":"1997","journal-title":"Am J Respir Crit Care Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"Am J Respir Crit Care Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.chest.2017.04.167","article-title":"Pharmacotherapy for non-cystic fibrosis bronchiectasis: results from an NTM Info & research patient survey and the bronchiectasis and NTM research registry","volume":"152","author":"Henkle","year":"2017","journal-title":"Chest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"CD000996","DOI":"10.1002\/14651858.CD000996.pub3","article-title":"Inhaled corticosteroids for bronchiectasis","volume":"5","author":"Kapur","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1136\/thoraxjnl-2013-203773","article-title":"The yin and the yang of immunosuppression with inhaled corticosteroids","volume":"68","author":"Sabroe","year":"2013","journal-title":"Thorax."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1753466620963030","DOI":"10.1177\/1753466620963030","article-title":"Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study","volume":"14","author":"Choi","year":"2020","journal-title":"Ther Adv Respir Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3109\/15412555.2015.1081162","article-title":"Association of inhaled corticosteroids with incident pneumonia and mortality in COPD patients; systematic review and meta-analysis","volume":"13","author":"Festic","year":"2016","journal-title":"COPD."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.812775\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T08:53:06Z","timestamp":1642755186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.812775\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":52,"alternative-id":["10.3389\/fmed.2021.812775"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.812775","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"article-number":"812775"}}